of regulation uses a kinase-independent mechanism and is mediated by a motif in Plk2 that is distinct from classical polo kinase substrate targeting domains. These results suggest that the NSF-Plk2 connection comprises a homeostatic sensor to directly link synaptic overactivity and subsequent downregulation in synaptic strength.
RESULTS

Plk2 target identification
We conducted an affinity chromatography screen using glutathione-S-transferase (GST) fused to the C-terminal half of Plk2 (Plk2c), a region containing the conserved polo box domain (PBD; Fig. 1a) , which is considered to be essential for polo-like kinase substrate interactions 19 . Rat brain lysates were applied to a column of GST-Plk2c or control GST. After extensive washing and elution, we subjected proteins recovered in GST-Plk2c eluates to mass spectrometry. Notably, this analysis identified several proteins involved in endocytosis (Supplementary Table 1 ), suggesting that Plk2 may regulate postsynaptic membrane dynamics.
For target validation, we performed additional GST-Plk2c pulldowns, followed by immunoblotting for candidate interactors. Alpha, beta and gamma adaptins, components of the AP1 and AP2 clathrin adaptor complexes, and NSF were recovered by GST-Plk2c, but not by GST alone (Fig. 1b) . As positive controls, known Plk2-interacting proteins tubulin 20 and SPAR 15 were specifically retained by GSTPlk2c ( Fig. 1b and Supplementary Fig. 1 ). Dynamin, however, bound equally well to GST and GST-Plk2c and was not examined further. NSF and tubulin were largely retained even under stringent pulldown conditions incorporating brief treatment with the strong 1 2 0 0 VOLUME 13 | NUMBER 10 | OCTOBER 2010 nature neurOSCIenCe a r t I C l e S detergent SDS, whereas other candidate interactors were lost (Fig. 1b) . Thus, the NSF-Plk2 interaction was specific and robust.
NSF and Plk2 bind directly in an ATP-dependent manner
To test for direct interaction, we conducted in vitro binding assays with purified hexahistidine-tagged NSF (His 6 -NSF) and GST, GST-Plk2c or GST fused to the GluA2 C terminus (GST-GluA2c). Because NSF interactions are often regulated by ATP 5 , binding assays were performed in the presence of ADP, ATP or the nonhydrolyzable analog ATPγS. Using GST pulldown, we found that GST-Plk2c and His 6 -NSF bound in this completely defined system (Fig. 1c) , indicating direct contact. Furthermore, Plk2c and NSF bound most strongly in the presence of ATPγS, similar to the interaction between NSF and GST-GluA2c 5 (Fig. 1c) . However, neither Plk2c nor GluA2c affected NSF-intrinsic ATPase activity (Supplementary Fig. 2 ).
When coexpressed in COS-7 cells, the full-length NSF and Plk2 proteins could be bidirectionally co-immunoprecipitated (Fig. 1d) . Kinase-negative, constitutively active and wild-type Plk2 bound to NSF equivalently (Fig. 1e) , suggesting that Plk2 kinase activity does not regulate this interaction. Fluorescence lifetime microscopy, a technique for reporting molecular proximity (<10 nm) between fluorescently tagged proteins (see Online Methods), indicated that Plk2 and kinase-dead Plk2 were closely associated with NSF ( Fig. 1f and Supplementary Table 2) .
To analyze the interaction of endogenous NSF and Plk2, we used cultured cortical neurons (18-21 d in vitro, DIV). Because basal Plk2 expression is low, we stimulated neuronal activity with the GABA A receptor antagonist picrotoxin (PTX, 100 μM, 24 h), which has been shown to robustly induce Plk2 expression 15, 17 . Following stimulation, antibodies to NSF, but not control IgG, recovered abundant Plk2 from neuronal lysates (Fig. 1g) . These results indicate that Plk2 and NSF strongly interacted in neurons following chronic stimulation of synaptic activity. Finally, NSF and Plk2 could also be co-immunoprecipitated from rat brain lysate (Fig. 1h) , suggesting that native Plk2 and NSF bound in vivo.
Plk2 exchanges GluA2-bound NSF for PICK1/GRIP1 An important question is whether Plk2 regulates NSF's interaction with GluA2 (Fig. 2) . We first verified that NSF and GluA2 could be co-immunoprecipitated in both directions when expressed by themselves in COS-7 cells (Fig. 2a) . However, coexpression of Plk2 completely prevented NSF and GluA2 binding, with concomitant association of Plk2 with NSF (Fig. 2a) . No binding of Plk2 was observed with GluA2 ( Fig. 2a,d,e) . Therefore, Plk2 and GluA2 bound NSF in a mutually exclusive fashion, with Plk2 being dominant. Notably, Plk2 co-precipitation with NSF was enhanced when GluA2 was coexpressed (Fig. 2b) , suggesting that Plk2 has higher affinity for NSF that is bound to GluA2.
To determine whether Plk2 could disrupt native GluA2-NSF complexes, we infected hippocampal cultures (18) (19) (20) (21) at saturating titers with Sindbis virus expressing Plk2 (Sind-Plk2) or green fluorescent protein (GFP, Sind-GFP). In GFP-expressing neurons, NSF co-immunoprecipitated readily with GluA2, but modestly immunoprecipitated with the limited pool of basal Plk2 (Fig. 2c) . In contrast, NSF interaction with GluA2 was abolished in Sind-Plk2-infected neurons; instead, NSF strongly associated with the Plk2 (Fig. 2c) . Thus, Plk2 attachment to NSF efficiently displaced the interaction of NSF with GluA2 in neurons. Notably, PTX induction of Plk2 also completely disrupted NSF-GluA2 interaction, whereas the association of GluA2 and the adaptor PICK1 was considerably augmented in the same stimulated cultures (Fig. 2d) .
The fate of GluA2 that dissociated from NSF was further probed using hippocampal cultures infected with Sind-Plk2 or Sind-GFP and immunoprecipitated for GluA2. Accompanying Plk2-induced disruption of GluA2 and NSF binding, GluA2's association with both PICK1 and GRIP1, adaptor proteins that have been implicated in binding GluA2 intracellularly 10, 21, 22 , was markedly increased (Fig. 2e) . In addition, Plk2 expression enhanced GluA2 serine 880 phosphorylation (Fig. 2f) , a PKC-dependent biochemical signature of PICK1 binding, GluA2 endocytosis and long-term depression 10, 23 (but see Figure a r t I C l e S ref. 24 ). As total GluA2 levels always remained constant ( Fig. 2c-f ), these data suggest that disruption of GluA2-NSF binding by Plk2 promotes the redistribution of GluA2 among adaptor proteins and intracellular sequestration.
Plk2 reduces surface GluA2 expression via NSF
We used surface biotinylation assays to assess the effect of Plk2 on GluA2 surface expression in COS-7 cells. As expected, cells that were transfected with Plk2 (or Plk2 and NSF together) had a large decrease in surface GluA2 (sGluA2) expression compared with cells in which GluA2 was transfected alone (Fig. 2g,h ). The effect of Plk2 by itself on sGluA2 was likely mediated through endogenous NSF present in COS-7 cells. Similar results were obtained by surface immunostaining of GluA2 expressed in HEK cells (co-transfected with Plk2 and/or NSF) using an extracellular epitope-directed GluA2 antibody under nonpermeabilizing conditions (Fig. 2i,j) . Unexpectedly, NSF itself decreased sGluA2 in heterologous cells (Fig. 2g-j) and in NSFoverexpressing hippocampal neurons ( Supplementary Fig. 3 ), albeit less potently than Plk2, possibly as a result of excess intracellular NSF impeding GluA2 membrane trafficking to the cell surface. We next examined the effect of Plk2 on endogenous GluA2 surface expression (Fig. 3) . We infected primary hippocampal cultured neurons (18-21 DIV) with Sind-Plk2 and live-labeled for surface GluA2 with N-terminal antibodies. Expression of steady-state sGluA2 was markedly decreased in secondary dendrites by Sind-Plk2 compared with Sind-GFP (Fig. 3a,c) , whereas surface GluA1 (sGluA1) expression was only modestly decreased (Fig. 3a,d) . No change was observed in total GluA1 or GluA2 under any conditions (Fig. 3b-d) , suggesting that there was an alteration in receptor trafficking rather than in metabolism. NSF levels and distribution were also unchanged ( Supplementary Fig. 3) , consistent with the lack of degradation of NSF by Plk2 in COS-7 cells and neuronal lysates. We observed an even greater effect of Plk2 on neuronal cell bodies that displayed virtually undetectable levels of sGluA2, whereas somatic sGluA1 levels were slightly, but not significantly (P = 0.06), decreased by Plk2 expression (Fig. 3e) . Thus, Plk2 can specifically and potently remove all sGluA2-containing receptors.
We previously found that Plk2 causes synapse elimination, primarily in proximal dendrites 15 . Although the preferential effects on sGluA2 versus sGluA1 were unlikely to be secondary to synapse loss, we analyzed PSD-95 puncta in Plk2-infected neurons and found no changes in secondary dendrites in which we observed strong depletion of sGluA2 ( Supplementary Fig. 4 ). These data suggest that surface AMPARs were lost from otherwise intact postsynaptic sites. Furthermore, we confirmed that transfection of Sind-Plk2 abolished PSD-95 immunofluorescence in proximal primary dendrites ( Supplementary Fig. 4) , as was previously shown 15 . Loss of PSD-95 in proximal dendrites required Plk2 kinase activity, as we found increased proximal PSD-95 levels in cells transfected with kinasenegative Plk2 (Sind-Plk2-KN; Supplementary Fig. 4 ), a construct that exerts dominant-negative effects 15 . To our surprise, Plk2 reduction of sGluA2 did not require kinase activity and occurred equally with transfection of either Plk2 or Plk2-KN (Fig. 3a,c) . Thus, the actions of Plk2 on synapse elimination and GluA2 are mechanistically dissociable by dendritic locus and kinase dependence.
To ask whether endogenous Plk2 regulates sGluA2 levels, we used PTX stimulation to induce Plk2 expression. We observed considerable cell-to-cell variability in basal Plk2 levels and Plk2 induction, likely as a function of heterogeneity of synaptic input in dissociated cell culture. Nevertheless, the level of sGluA2 in secondary dendrites (g) COS-7 cells were transfected and cell surface proteins were biotin-labeled, isolated with avidin-beads and immunoblotted for total GluA2 and sGluA2. (h) Quantification of data in g; sGluA2 was normalized to total GluA2 and plotted as the percentage of the control. **P < 0.01 and ***P < 0.001. (i) HEK cells were transfected and immunostained for sGluA2 (top) and total GluA2 (middle), corresponding to red and green, respectively, in the merged image (bottom). Scale bar represents 10 μm. (j) Quantification of surface to total GluA2 ratio from i. Error bars indicate s.e.m. a r t I C l e S was, on average, substantially decreased after PTX treatment (Fig. 4a,b) . Quantifying Plk2 expression and sGluA2 intensity in individual neurons revealed a strong negative correlation (Fig. 4c) , suggesting that endogenous Plk2 downregulates sGluA2 in a dosedependent manner. However, a ceiling effect could be seen in the flattening of the best-fit line for induced cultures, approaching a maximal value of ~75% loss of sGluA2 (Fig. 4c) , similar to values obtained with Plk2 overexpression. There was also a modest loss of sGluA1 with PTX stimulation in secondary dendrites (Fig. 4a,b) , but no change in total GluA2 (Fig. 4a,b) or PSD-95 (Supplementary Fig. 4) .
To perturb Plk2 function in this process, we developed an RNA interference (RNAi) construct that decreased basal Plk2 immunoreactivity in neurons, prevented Plk2 induction by PTX and efficiently knocked down Plk2 expression in heterologous cells (Supplementary Fig. 5 ). In vector controltransfected neurons, sGluA2 immunofluorescence was again strongly reduced by PTX treatment (Fig. 4d,e) . However, PTXinduced loss of sGluA2 was fully blocked by Plk2 knockdown (Fig. 4d,e) and restored by co-transfection of a Plk2 rescue construct (Fig. 4e) that was insensitive to the RNAi (Supplementary Fig. 5 ). We conclude that Plk2 is both necessary and sufficient for overexcitation-induced downregulation of sGluA2.
Decreased surface expression of GluA2 could result from impaired cell surface delivery, increased internalization or both. To distinguish these possibilities, we livelabeled sGluA2 and conducted internalization assays to analyze the endocytosis of GluA2-containing AMPARs and recycling assays to measure their rate of return to the cell surface (Online Methods). Plk2 slightly increased the absolute rate of GluA2 internalization (at 30 min, GFP = 10.3 ± 2.1, Plk2 = 12.2 ± 2.2, P = 0.35; Fig. 5a ) and decreased its recycling (GFP = 40.5 ± 4.7, Plk2 = 35.6 ± 4.0, P = 0.19; Fig. 5b,c) , although neither effect was significant. However, these data do not account for the greatly reduced pool of available sGluA2 and consequently increased pool of intracellular GluA2 in Plk2-expressing cells, as shown by both surface staining and biotinylation (Fig. 5a,d,e) . When expressed as the ratio of internalized to available surface receptors, the rate of sGluA2 internalization per receptor was elevated in Sind-Plk2-versus Sind-GFP-transfected neurons at all of the time points that we examined (Fig. 5f) . Similarly, Plk2 suppressed the rate of sGluA2 recycling per available intracellular receptor (Fig. 5c) . Thus, Plk2 increases the fraction of surface GluA2 receptors undergoing endocytosis and decreases the fraction that is subsequently reinserted.
To test the involvement of NSF in Plk2-mediated loss of sGluA2, we performed occlusion experiments using N-ethylmalemide (NEM), a thiolreactive compound that inhibits NSF function. NEM greatly reduced sGluA2 expression, quantitatively resembling the effect of Plk2; however, in Plk2-infected neurons, NEM treatment was largely occluded (Supplementary Fig. 6 ). Because NEM does not act specifically against NSF, we also used previously characterized peptide inhibitors of NSF (Fig. 6a-c) . Pep2m contains the NSF binding site on the GluA2 C terminus and inhibits the NSF-GluA2 interaction, causing a loss of surface AMPARs and rundown of AMPAR-mediated miniature excitatory postsynaptic currents (EPSCs) 3,4,6,11 . However, pep2m In contrast, pepR845A (pepRA) specifically inhibits NSF binding to GluA2 without affecting AP2, whereas the control peptide pepK844A (pepKA) does not interfere with either NSF or AP2 (ref. 25) . As with NEM, pepRA markedly lowered sGluA2 expression and coexpressing pepRA and Plk2 did not cause a larger decrease than Plk2 or pepRA alone (Fig. 6a,b) ; similar results were observed for pep2m (data not shown; quantified in Fig. 6c) . The pepKA control did not affect sGluA2 expression or removal of sGluA2 by Plk2 (Fig. 6a,b) . Occlusion of the effects of Plk2 by pep2m and pepRA further supports the idea that Plk2 decreases sGluA2 through NSF.
NSF binds a PBD-independent motif Given Plk2's atypical kinase-independent regulation of sGluA2, we sought to characterize the NSF-Plk2 interaction in greater detail. First, we confirmed that the Plk2c C-terminal fragment, which lacks the kinase domain, but contains the PBD and is sufficient to bind NSF (Fig. 1a-c) , caused a reduction in sGluA2 immunofluorescence intensity similar to that of fulllength Plk2 (Fig. 7a,b) . In contrast, Plk2c had no effect on postsynapse number, as suggested by unchanged PSD-95 signal ( Supplementary  Fig. 7) . Notably, mutation of a residue (W504F) required for PBDmediated interactions 19, 26 , including Plk2 binding to SPAR 17 , failed to prevent co-immunoprecipitation of Plk2 and NSF from COS-7 cells (Fig. 7c) . Furthermore, Plk2-W504F-transfected neurons had decreased sGluA2 with similar potency to wild-type Plk2 (Fig. 7a,b) . Thus, the ability of Plk2 to bind NSF and to regulate sGluA2 was independent of the PBD, implying the existence of an unknown interaction site. To map this putative site, we conducted deletion analysis of the NSF-binding Plk2c region using yeast two-hybrid (Y2H) assays. PBD primary structure consists of two homologous polo boxes and a linker region between the kinase domain and the PBD (Fig. 7d) . We examined NSF's interaction with various fragments of the two polo boxes, the linker region or their flanking regions. NSF bound to a region (amino acids 395-480) near the N-terminal boundary of Plk2c that did not include either polo box (Fig. 7d) .
A series of additional deletions revealed that a minimal 24-residue polypeptide of Plk2 (amino acids 430-453) was sufficient for binding NSF (Fig. 7d) . This region included no portion of the PBD and thus represents a previously unidentified polo kinase interaction site; we have termed this element the polo box independent (PBind) site. Alignment of Plk2 and the highly related Plk3, which also binds NSF (data not shown), identified two clusters of conserved residues (Fig. 7d) . Site-directed mutagenesis of each conserved amino acid to alanine revealed that multiple residues contributed to the NSF interaction (Fig. 7d) .
Conversely, to explore the binding site for Plk2 on NSF, we used Y2H analysis of individual domains of NSF (N domain and two homologous ATP binding domains D1 and D2) and found that no single domain was sufficient for the PBind interaction (Fig. 7e) . Similarly, all of the NSF domains are required for binding to GluA2 (ref. 3) , suggesting that the overall structure of NSF may be important for both Plk2 and GluA2 recognition. In addition, we found that Plk2 interaction was abolished by an ATP-binding mutation of NSF (K266A), but unaffected by an ATPase-deficient mutation (E329A) (Fig. 7e) . These results suggest that ATP binding, but not hydrolysis, is necessary for NSF to recruit Plk2.
Plk2 binding NSF is sufficient to remove synaptic AMPARs PBind fused to GFP was able to co-immunoprecipitate with NSF when coexpressed in COS-7 cells (Fig. 8a) and a purified fusion of maltose-binding protein (MBP) and PBind (MBP-PBind) was able to pull-down native NSF from rat brain lysate (Fig. 8b) , confirming that the minimal PBind motif interacted with NSF. Furthermore, expression of GFP-PBind in cultured hippocampal neurons, but not GFP alone, fully mimicked the loss of sGluA2 immunofluorescence that we observed in Plk2-transfected cells (Fig. 8c) .
Finally, we used a synthetic peptide comprising the PBind site (pep-pBind) to investigate the physiological effect of Plk2 binding NSF on synaptic AMPARs. We first verified via surface plasmon a r t I C l e S resonance that pep-PBind and purified His 6 -NSF bound directly, whereas a peptide with a scrambled PBind sequence (pep-scr) did not interact with NSF (Fig. 8d) . We then recorded synaptic AMPAR EPSCs from CA1 pyramidal neurons in acute hippocampal slices while electrically stimulating the Schaffer collateral input. We dialyzed pyramidal neurons with pep-PBind in the intracellular solution and observed a time-dependent decrease in EPSCs to ~57% of its initial amplitude, whereas pep-scr caused no significant change (P = 0.17) in EPSC amplitude (Fig. 8e,f) . These results strongly suggest that binding of NSF by the PBind site of Plk2 is sufficient to disrupt NSF-GluA2 interaction and induce a rapid loss of synaptic AMPARs.
DISCUSSION
Homeostatic synaptic plasticity is thought to be important for stabilization of neuronal firing in an optimal operational range despite a r t I C l e S fluctuations in network activity 27 , but the mechanisms involved are not fully understood. We found that direct Plk2 binding to NSF was sufficient to cause its dissociation from GluA2. As Plk2 did not accelerate ATP hydrolysis by NSF, and NSF binding to Plk2 and GluA2 appeared to be comparable (Fig. 1c) , we favor a model in which Plk2 exerts an allosteric conformational change in NSF that dislodges GluA2. The observed potency of such a noncatalytic mechanism may be explained in at least two ways. First, Plk2's affinity for NSF increased when NSF was bound to GluA2 (Fig. 2b) . Second, stabilization of Plk2 binding to NSF by ATPγ S, reminiscent of the GluA2-NSF interaction, suggests that ATP-dependent cycling of Plk2 attachment to NSF could allow Plk2 to act processively on multiple NSF-GluA2 complexes.
A consequence of disrupting NSF-GluA2 interaction was the loss of sGluA2, but not sGluA1. Such preference mirrors the binding specificity of NSF for these subunits [3] [4] [5] [6] 25 and is consistent with the specific requirement for GluA2 in homeostatic synaptic scaling 28 . Furthermore, we found that all sGluA2, dendritic as well as somatic, was subject to removal by Plk2. The specificity of action against GluA2 surface trafficking differs from that seen in previous reports that blocked the NSF-GluA2 interaction 11, 25 . However, our study is, to the best of our knowledge, the first to exploit an endogenous mechanism to perturb NSF-GluA2, which may exhibit different properties than nonphysiological competitive peptides.
As the majority of AMPARs in hippocampus consist of GluA1/2 heteromers 29, 30 , nearly complete depletion of sGluA2 with minimal effect on sGluA1 could be achieved by delivery of GluA1/3 heteromers or homomeric GluA1 to partly compensate for lost GluA2. Homomeric GluA1 insertion has been previously observed in various forms of synaptic plasticity [31] [32] [33] , in response to brain injury 34 and in GluA2 knockout mice 29 . Extensive loss of sGluA2 by Plk2, as detected during homeostatic plasticity, suggests that GluA2-independent AMPAR trafficking 35-37 may represent physiological mechanisms, rather than compensatory ones. Reduced GluA2 levels could contribute to decreased synaptic strength as a result of fewer synaptic receptors and to increased calcium permeability, a property of GluA2-lacking receptors 8, 29, 38 . Both functions may be important for adaptation to hyperactivity; for example, GluA2-lacking neurons undergo AMPAR internalization with more extensive spatial distribution 37 .
Plk2 caused rapid depletion of sGluA2 via heightened endocytosis and impaired receptor recycling, rather than by degradation, as total GluA2 levels were not sensitive to Plk2 expression. These results are consistent with previous reports that NSF constrains internalization 7, 25 , but can promote receptor insertion [39] [40] [41] [42] [43] . NSF disassembles GluA2 from PICK1 (ref. 44 ), a transport molecule that has also been implicated in both AMPAR endocytosis 10, 23, 45, 46 and surface delivery 21 . Our data support this dual role of NSF and PICK1 in ii.
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Point mutation template a r t I C l e S AMPAR endocytosis/exocytosis; deprived of access to NSF by Plk2, GluA2 became trapped in greater complex with PICK1, which simultaneously promoted its endocytosis and hindered its release from intracellular retention. Plk2 also increased GluA2 phosphorylation at ser880, a PKC-dependent modification promoted by PICK1 (refs. 10,23). Our results suggest that ser880 phosphorylation correlates with the removal of sGluA2, at least during homeostatic adaptation to overactivity, in contrast with a previous study that used primarily exogenous receptors and PKC stimulation 24 ; such technical differences may explain these inconsistencies. Notably, Plk2 also markedly increased GluA2's association with GRIP1. GRIP/ABP family scaffolds have been proposed to tether AMPARs at synapses 47 and intracellularly 7, 21 . However, our data suggest that GRIP1 is primarily involved at intracellular sites, although other GRIP/ABP family members may be more synaptically localized, possibly depending on palmitoylation state 48 . Because GluA2 ser880 phosphorylation blocks GRIP binding 49 , our data support the existence of two pools of intracellular GluA2, one tethered by GRIP1 and another associated with PICK1, which may reflect anchored and mobile pools, respectively 21 . The negligible amount of GluA2 associated with GRIP1 or PICK1 under basal conditions may explain the low level of AMPAR interaction of these adapters reported previously 50 and also suggests that GRIP1 and PICK1 do not constitutively retain large reserves of intracellular AMPARs until recruited by activity.
Another major finding of this work is the identification of a previously unknown mode of polo-like kinase function. Plk2 has previously been implicated in homeostatic downscaling following overactivity via a mechanism that is critically dependent on PBD recognition and phosphorylation-induced degradation of SPAR 17 . In contrast, removal of sGluA2 by Plk2 was independent of both kinase activity and the classical PBD-targeting domain of polo kinases. Disruption of NSFGluA2 interaction, loss of sGluA2 and rapid rundown of AMPAR currents were caused by simple binding of NSF by the minimal 24-residue PBind region of Plk2. These findings uncover an additional regulatory mode that expands the repertoire by which polo-like kinases may exert influence over binding partners.
Although Plk2 kinase activity results in loss of proximal dendritic excitatory synapses 15 , the kinase-independent mechanism that we examined affected sGluA2 in secondary dendrites in which postsynaptic loss was not evident. The mechanisms that restrict synapse loss to mainly proximal dendrites are currently unknown; we speculate that competing phosphatase activity may exist that is overcome only in proximal dendrites in which Plk2 expression is highest. Regardless, it is clear that two distinct homeostatic mechanisms are governed by Plk2, which may support complementary functions.
We propose that NSF acts as a one-way homeostatic gate (Supplementary Fig. 8 ) that corrals sGluA2 by continual detachment of GluA2 from PICK1, dynamically retrieving GluA2 from endocytic zones and promoting its reinsertion from intracellular mobile pools. Activity-induced Plk2 engages and reverses this gating mechanism to allow graded endocytosis of sGluA2 while slowing down recycling, providing continuous homeostatic negative feedback in direct proportion to the level of activity recently experienced. Plk2-NSF interactions observed under basal conditions of synaptic activity in cultured hippocampal neurons and in brain further suggest that this kinase-independent noncatalytic mechanism may operate over a fairly wide dynamic range rather than just during overstimulation.
In the event of sustained hyperactivity, the Plk2 kinase-dependent pathway may be invoked to target postsynaptic substrates for degradation, leading to an all-or-none loss of synapses. We envision that such a tiered response system, perhaps in concert with other previously described activity-inducible factors 27 , enables homeostatic negative feedback mechanisms to compensate for a continuum of synaptic input levels ranging from normal ongoing activity to excitotoxic insults. 
